Dunn Edmund (CIK 1989401) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-05). Recent activity: Sell GLUE (139 shares), Buy GLUE (25,164 shares), Sell GLUE (25,164 shares), Buy GLUE (536 shares), Sell GLUE (536 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-05 | Monte Rosa Therapeutics, Inc. (GLUE) | Principal Accounting Officer | Sell | 139 | $2,496 |
| 2026-03-02 | Monte Rosa Therapeutics, Inc. (GLUE) | Principal Accounting Officer | Buy | 25,164 | $337,449 |
| 2026-03-02 | Monte Rosa Therapeutics, Inc. (GLUE) | Principal Accounting Officer | Sell | 25,164 | $455,468 |
| 2026-03-02 | Monte Rosa Therapeutics, Inc. (GLUE) | Principal Accounting Officer | Buy | 536 | $7,188 |
| 2026-03-02 | Monte Rosa Therapeutics, Inc. (GLUE) | Principal Accounting Officer | Sell | 536 | $9,380 |
| 2026-01-05 | Monte Rosa Therapeutics, Inc. (GLUE) | Principal Accounting Officer | Sell | 1,039 | $15,762 |
| 2025-06-04 | Monte Rosa Therapeutics, Inc. (GLUE) | Principal Accounting Officer | Sell | 2,062 | $9,176 |
来源：SEC Form 4 申报文件 · 截至 2026-03-05